Japanese drugs firm Takeda has won shareholder approval for its £46 billion acquisition of Shire, paving the way for the deal to create one of the biggest pharmaceutical firms in the world. Japanese drugs firm Takeda has won shareholder approval for its £46 billion acquisition of Shire, paving the way for the deal to create one of the biggest pharmaceutical firms in the world. Takeda said it won support from at least 88% of its shareholders at an extraordinary general meeting in Osaka on Wednesday. Shire investors also overwhelmingly gave the deal the thumbs up, with 99.8% of investors voting in favour, which means the deal is now expected to complete on January 8. Takeda reached a deal in May to buy Irish rival Shire for £49.01 a share.

Source: Irish Independent December 05, 2018 14:48 UTC